Oral Oncol 2022 May 27
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.
Related Questions
If using cetuximab, would you recommend accelerated fractionation?
New answer by Radiation Oncologist at University of Florida (June 27, 2023)
Altered fractionation, preferably hyper fractionation, and a taxane. If hyper fractionation is not an option, 6-week SIB.